baber/WOPTO huggingface dataset:
Patent DK-2797493-T3 (DK)
Inventor: MASSOW OLE
IPC: G01B11/02
Filed: 2011-12-28
Granted: 2018-09-03
Abstract: In a process for optical coherence tomography a plurality of first OCT slice images (34), each first slice image representing a different slice of an object (12), are recorded. Subsequently a reference figure (44) that is representative of the three-dimensional contour of at least one structural feature (36) of the object (12) in a given three-dimensional coordinate system x, y, z is ascertained by feature recognition of the at least one structural feature (36) in the first slice images (34). Then a plurality of second OCT slice images (46), each second slice image representing a different slice of the object (12), are recorded. At least a fraction of the second slice images (46) are displaced in the coordinate system x, y, z until each second slice image (46) is in feature overlap with the reference figure (44). Lastly, a set of three-dimensional OCT image data is generated at least from the feature-overlapped second slice images (46).
Patent DK-2796549-T3 (DK)
Inventor: SHIN SOO AN
IPC: C12P13/12
Filed: 2011-10-19
Granted: 2018-06-14
Abstract: Disclosed is an O-phosphoserine sulfhydrylase (OPSS) mutant which has a Mycobacterium smegmatis-derived amino acid sequence corresponding to that of SEQ ID NO: 1 which is devoid of three to seven C-terminal amino acid residues. Also, a nucleic acid molecule encoding the OPSS mutant, an expression vector carrying the nucleic acid molecule, and a transformant transformed with the expression vector are disclosed. In addition, a method is provided for producing cysteine in which O-phospho-L-serine (OPS) is reacted with a sulfide in the presence of the OPSS mutant. The OPSS mutant has improved enzymatic activity and can be applied to the environmentally friendly production of L-cysteine through a simple enzymatic conversion reaction.
Patent DK-3003067-T3 (DK)
Inventor: INNINGS FREDRIK
IPC: A23L5/00
Filed: 2014-05-27
Granted: 2018-03-05
Abstract: A method for providing a heat treated liquid product is provided. The method comprises the steps of heating a flow of liquid product; providing an ice slurry of sterile water being separated from said flow of liquid product; and combining said flow of liquid product with said ice slurry for cooling down the flow of liquid product.
Patent DK-2962690-T3 (DK)
Inventor: SCHAFER PETER H
IPC: C07D209/48
Filed: 2003-03-20
Granted: 2019-04-15
Abstract: Discussed is stereomerically pure (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, or a pharmaceutically acceptable polymorph, salt, solvate or hydrate thereof, as well as a pharmaceutical composition or single unit dosage form comprising such compound and such compound for use as a medicine.
Patent DK-3096515-T3 (DK)
Inventor: KADONO SHINYA
IPC: H04N7/52
Filed: 2003-04-10
Granted: 2018-08-06
Abstract: The present invention provides an image coding method and an image decoding method by which an image can be restored correctly even if part of memory management information is lost by a transmission channel error, a candidate of a reference image that can be referred to is selected more appropriately, and coding efficiency is improved. <??>The image coding method includes a step for executing coding of an image (Step 100), a step for judging whether a picture in the memory which is never used as reference exists (Step 102), a step for coding memory management information for releasing the picture in the memory which is never used as reference when a picture in the memory which is never used as reference exists (Step 103), a step for releasing the picture in the memory which is never used as reference (Step 104), a step for judging whether the memory management information that releases the picture in the memory which is never used as reference is coded by coding of an image immediately before (Step 105), and a step for coding again the memory management information that releases the picture in the memory which is never used as reference when the memory management information is coded (Step 106). <IMAGE>
Patent DK-0382252-T3 (DK)
Inventor: PETERS REINER
IPC: B65B67/04
Filed: 1990-02-09
Granted: 1992-08-24
Abstract: PCT No. PCT/EP90/00217 Sec. 371 Date Oct. 4, 1990 Sec. 102(e) Date Oct. 4, 1990 PCT Filed Feb. 9, 1990 PCT Pub. No. WO90/09318 PCT Pub. Date Aug. 23, 1990.An upright immersion tube (92) is movable back and forth in its longitudinal direction between a takeover position in which a bushy plant (10) can be introduced into the immersion tube (92) and an immersed position in which the immersion tube is plunged through a spreader tube (40) into the vicinity of the bottom of a bag (12) which is being held open. The immersion tube (92) has a rear semi-tubular portion (96) with a hinged flap which is open in the takeover position but adapted to be moved into a closing position as the immersion tube (92) moves into the immersed position and, in said closing position, supplements the rear portion (96) so as to form a closed tube section. The spreader tube (40) has the profile contour of a ship's hull and engages between projecting bag edge zones (16) of a film web forming the bags (12) and being movable stepwise in the longitudinal direction of this contour. The flap is a semi-tubular portion of the imemrsion tube (92) and, with the conveyor chute (98) in the open position, it aligns one bushy plant (10) each in longitudinal direction of the immersion tube (92), with the root conglomerate leading.
Patent DK-0400522-T3 (DK)
Inventor: MUACEVIC GOJKO DR
IPC: A61K9/16
Filed: 1990-05-28
Granted: 1995-04-03
Abstract: The invention relates to micronised biodegradable particles, to a process for their preparation and to their use.
Patent DK-0420042-T3 (DK)
Inventor: MOEST THOMAS DR
IPC: A61K9/20
Filed: 1990-09-20
Granted: 1992-10-05
Abstract: A solid pharmaceutical form with a verapamil content of at least 90 % by weight is produced by granulation at 30 to 50 DEG C with a little water, drying and, where appropriate, conventional tabletting or by pelleting, where the granules obtained as described are, after cooling, moistened once again and compacted and dried in a granulating mixer at 30 to 55 DEG C.
Patent DK-0393771-T3 (DK)
Inventor: JONG D DE
IPC: A01J25/16
Filed: 1990-04-13
Granted: 1994-11-21
Abstract: A device for bearing a perishable foodstuff, in particular a cheese, whereby the device is provided with at least one bearing tray (2) that is permeable to gas and with means (1) which allow a gas to gain access from the bottom side of the bearing tray (2), through the bearing tray (2) because of its permeability to gas, to the foodstuff to be placed on the bearing tray (2), or whereby the device is provided with at least one bearing tray (2) provided with means (10) projecting above its top surface which allow gas to gain access  from the side of the bearing tray (2), along the means (10), to the foodstuff to be placed on the bearing tray.
Patent DK-0414563-T3 (DK)
Inventor: NIETO ROBERT L
IPC: A61B5/15
Filed: 1990-08-24
Granted: 1995-12-11
Abstract: A lancet ejector device (60) for use in combination with a lancet injecting mechanism (10). The lancet ejector (60) of the present invention enables the user to eject a lancet (40) from the lancet injecting device without touching a used lancet.
Patent DK-0399949-T3 (DK)
Inventor: MAIER LUDWIG DR
IPC: A61P25/08
Filed: 1990-05-08
Granted: 1995-07-03
Abstract: P-substituted aminoalkylphosphinic acids of the formula <CHEM> wherein R denotes an optionally fluorinated methyl group, R1 denotes hydrogen, lower alkyl, lower alkoxy, hydroxy, halogen or a fluorinated methyl group and R2 and R3 denote hydrogen or R2 denotes hydroxy, lower alkoxy or halogen and R3 is hydrogen or R2 and R3 together represent an oxo group, and their pharmaceutically acceptable salts are active as GABAB agonists and can be used in the treatment of spinal spasticity, multiple sclerosis and cerebral palsy, trigeminus neuralgia, drug withdrawal syndromes and/or conditions of pain. They can be manufactured by methods known per se and suitable such methods are described.
Patent DK-0454746-T3 (DK)
Inventor: BARTOSCHEK MANFRED
IPC: F16K31/50
Filed: 1990-01-09
Granted: 1993-11-22
Abstract: PCT No. PCT/EP90/00039 Sec. 371 Date Aug. 29, 1991 Sec. 102(e) Date Aug. 29, 1991 PCT Filed Jan. 9, 1990 PCT Pub. No. WO90/08282 PCT Pub. Date Jul. 26, 1990.A gate valve has a housing for a valve seat, and an attachment which extends outwardly from the housing and constitutes an extension thereof. A cap is secured to the attachment at the end of the latter remote from the housing, and a plate which traverses the attachment is held between the cap and the attachment. An externally threaded, non-rotary valve stem extends between the cap and the housing and passes through the plate. The valve stem meshes with an internally threaded, rotatable sleeve which receives the valve stem and is connected to a handwheel. The sleeve is at least partially confined by the cap and the plate, and both the cap and the plate are provided with bearing locations for the sleeve.
Patent DK-0471193-T3 (DK)
Inventor: LUENSMANN MARCUS
IPC: E06B3/30
Filed: 1991-07-16
Granted: 1993-05-17
Abstract: The profile for wood-metal frames for use in windows, doors or the like comprises at least one plastics clip (10) for fixing the metal profile (8) on a bearing surface of the wood profile (7), the clip being secured on the wood profile (7), by a base (11) against the said bearing surface and engaging by a clip wedge (12) in a locking manner between two metal profile webs (13) which extend in the longitudinal direction of the profile, each web having at its free edge which is supported on the base (11) an inwardly pointing retaining lug (14), the two lugs being mutually opposite and each engaging behind the free edge of one of the two limbs (12a, 12b) which form the clip wedge (12). In this arrangement, the connection between the wood profile (7) and the metal profile (8) can be made possible in a particularly simple manner if there is provided, for the purpose of securing the plastics clip (10), an approximately U-shaped sheet metal part (15) whose one end (insert end 16) is pushed into a recess (18 - 21) of the base (11) and is immobilised in this position, whereas the other U-arm (17) engages in a groove (5) made in the wood profile which extends in the longitudinal direction of said profile, and the U-web (15a) of the sheet metal part (15) rests on a strip (25) of the wood profile (7). <IMAGE>
Patent DK-0458685-T3 (DK)
Inventor: RENAULT FRANCOIS
IPC: F23D11/14
Filed: 1991-05-17
Granted: 1994-09-05
Abstract: The invention relates to a process for spraying a liquid with the aid of at least one auxiliary fluid, such as a gas, this process comprising the use of:     - an annular flow of the said liquid (27),   - an annular flow of a primary gas (38), - an annular flow of a secondary gas (23) which is identical to or different from the previous gas,  the said process consisting in:   a) directing the flow of liquid within the said flow of primary gas in the flow direction of the latter, b) producing an annular thin film of liquid by directing the coaxial flows of liquid and primary gas onto the periphery of a ring (30), one of the free ends of which is shaped in the form of a ridge,   c) spraying the liquid at the end of the said ridge.   According to the invention, the ratio of the total mass of gas with respect to the total mass of the liquid is less than 0.5. <IMAGE>
Patent DK-0545966-T3 (DK)
Inventor: MERTENS ALFRED
IPC: C07H19/20
Filed: 1991-08-14
Granted: 1995-05-08
Abstract: Compounds of the formula I   <IMAGE>   in which R1 and R2 represent a possibly substituted C8-C15-alkyl chain, n the number 0, 1 or 2 and A the residue of a nucleoside, processes for their preparation, as well as antiviral medicaments which contain these compounds.
Patent DK-0538951-T3 (DK)
Inventor: EBERT RAY FRANCIS
IPC: C12N5/071
Filed: 1992-10-20
Granted: 1999-04-26
Abstract: A method for preparing a thromboplastin reagent from cultured human cells comprising the steps of washing the cells with isotonic aqueous salt solution, lysing the cells by hypotonic shock, and resuspending the cell lysate in a diluent compatible with a one-stage prothrombin time determination to reach a concentration of about 0.5 to 3.0 mg/mL thromboplastin, whereby said cell lysate thromboplastin suspension produces a clot in a one stage prothrombin time test in about 10 to 15 seconds, with a mean normal prothrombin time of about 11-13 seconds, when added to citrated normal plasma in a volume ratio of about 2:1, such thromboplastin being stable for at least 8 hours at 37 DEG C and for at least 5 days at 4 DEG C.
Patent DK-0564476-T3 (DK)
Inventor: CARDUCK FRANZ-JOSEF
IPC: C11D3/382
Filed: 1991-12-06
Granted: 1995-09-04
Abstract: In the production of enzyme granulates with grain sizes from 0.1 to 2 mm, containing 2 to 20 % wt. proteases, lipases, amylases and/or cellulases, 10 to 50 % wt. swellable starch, 5 to 50 % wt. granulating agent, 3 to 12 % wt. water and not more than 10 % wt. water-soluble salt, by extruding an enzyme pre-mixture obtained by mixing a fermentation liquor cleared of insoluble components and concentrated with additives and spheroidizing the extrudate in a rounder, the use of relatively highly concentrated fermentation liquours has previously been necessary. By removing the insoluble components from the fermentation liquor by micro-filtration and mixing with additives which, in relation to the finished granulate, contains 10 to 35 % wt. cereal flour, it is possible, by the use of low-concentration fermentation liquors, to obtain highly active enzyme granulates with a long shelf life which are suitable for inclusion in washing and cleansing agents and are distinguished by uniform solubility properties in aqueous washing and cleansing baths.
Patent DK-0580078-T3 (DK)
Inventor: AHLERS MICHAEL DR
IPC: A23L33/00
Filed: 1993-07-15
Granted: 1998-05-25
Abstract: The invention relates to polyvinylamine derivatives containing hydrophilic centres, of the formula I <IMAGE> in which R<1>, R<2>, R<3>, X, w, x, y and z are as defined, and to a process for their preparation, and to the use of these compounds as medicaments (drugs, pharmaceuticals), active compound (active ingredient) carriers and as foodstuff auxiliaries. The preparation starts, in particular, from highly pure polyvinylamines containing the recurring unit of the formula Ia <IMAGE> whose preparation is likewise described.a
Patent DK-0589375-T3 (DK)
Inventor: MERGENS WILLIAM JOSEPH
IPC: A23L33/00
Filed: 1993-09-18
Granted: 1997-09-22
Abstract: Substantially dry micronutrient compositions comprise up to 15% by weight of a micronutrient, a binding amount of a binder, and a densifying amount of a densifying agent of particle size from approximately 40 mesh to approximately 325 mesh, and have a tapped density of from about 0.7 g/cm<3> to about 1.2 g/cm<3>, whereby the densifying agent is substantially coated with the micronutrient and the binder. The process for producing the compositions includes the steps of dissolving or dispersing appropriate amounts of the micronutrient and the binder in water, suspending an appropriate amount of the densifying agent in the so-obtained solution or dispersion and spray drying the resulting suspension, optionally in the presence of silicon dioxide, to produce the desired micronutrient composition. The invention also embraces the suspension. The substantially dry micronutrient compositions of the invention feature a considerably higher density than conventional micronutrient compositions.
Patent DK-0630428-T3 (DK)
Inventor: DEPREZ DOMINIQUE
IPC: C25B3/25
Filed: 1993-03-11
Granted: 1995-12-27
Abstract: Process for electrochemical preparation of taxane derivatives of general formula (I) based on a product of general formula (II). In general formula (I), Ar denotes an aryl radical, R1? is a benzoyl radical or R2?-O-CO- radical in which R2? is an alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, phenyl or heterocyclyl radical and R is a hydrogen atom of the acetyl radical. In general formula (II), Ar and R are defined as in general formula (I), R' is an acetyl or trichloro-2,2,2 ethoxycarbonyl radical and G1? is a trichloro-2,2,2 ethoxycarbonyl radical and G2? is a hydrogen atom. The products of general formula (I) have outstanding anti-tumoral properties.
Patent DK-0660676-T3 (DK)
Inventor: FORD MICHAEL ANTHONY
IPC: A23L33/15
Filed: 1993-09-13
Granted: 1997-06-02
Abstract: PCT No. PCT/GB93/01937 Sec. 371 Date Mar. 15, 1995 Sec. 102(e) Date Mar. 15, 1995 PCT Filed Sep. 13, 1993 PCT Pub. No. WO94/06310 PCT Pub. Date Mar. 31, 1994An aqueous composition for the preparation of optically clear products for use in human or animal healthcare comprising 0.1 to 2.0% w/w of an oil-soluble ingredient as a 20-30% w/w dispersion in a suitable oil or 0.1 to 5.0% w/v as the pure crystalline compound, 2-20% of an emulsifier having an HLB (hydrophilic/lipophilic balance) value of between 10 and 18 or where a blend of emulsifiers is employed, a calculated HLB value of between 10 and 18 and 0.1 to 1.0% of an antioxidant or a mixture of antioxidants. Processes for preparation of the compositions and their use in the preparation of beverages are provided.
Patent DK-0660716-T3 (DK)
Inventor: GARST MICHAEL E
IPC: A61P9/00
Filed: 1993-09-09
Granted: 2002-04-02
Abstract: The present invention provides cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives, substituted in the 1-position with halo, methyl, hydroxyl, nitro, amino, amido, azido, oxime, cyano, thiol, either or thioether groups, e.g., a 1-OH cyclopentane heptanoic acid, 2-(cycloalkyl or arylalkyl) derivatives. The cyclopentane heptanoic acid, 2-(cycloalkyl or arylalkyl) derivatives of the present invention are potent ocular hypotensives, and are particularly suitable for the management of glaucoma. Moreover, the cyclopentane heptanoic, 2-(cycloalkyl or arylalkyl) derivatives of this invention are smooth muscle relaxants with broad application in systemic hypertensive and pulmonary diseases; smooth muscle relaxants with application in gastrointestinal disease, reproduction, fertility, incontinence, shock, etc.
Patent DK-0633019-T3 (DK)
Inventor: HETTCHE HELMUT DR
IPC: C09K23/34
Filed: 1994-05-21
Granted: 2000-03-20
Abstract: Aerosol pressurised gas packs for administration of biologically active substances with novel suspension stabilisers and non-ozone-damaging propellants are described.
Patent DK-0690720-T3 (DK)
Inventor: LITTLE ROGER G II
IPC: A61P7/04
Filed: 1994-03-11
Granted: 2001-08-27
Abstract: The present invention provides therapeutic methods for treatment of conditions including the neutralization of the anti-coagulant activity of heparin, inhibition of angiogenesis, tumor and endothelial cell proliferation, and treatment of chronic inflammatory diseases by administration of bactericidal/permeability-increasing (BPI) protein products.
Patent DK-0691975-T3 (DK)
Inventor: PEYMAN ANUSCHIRWAN
IPC: C07F9/30
Filed: 1994-03-24
Granted: 1997-12-22
Abstract: PCT No. PCT/EP94/00950 Sec. 371 Date Sep. 28, 1995 Sec. 102(e) Date Sep. 28, 1995 PCT Filed Mar. 24, 1994 PCT Pub. No. WO94/22879 PCT Pub. Date Oct. 13, 1994Novel bis(aminomethyl)phosphinic acid derivatives and process for the preparation of bis(aminomethyl)phosphinic acid derivatives Compounds of the formula VI    <IMAGE>  (VI)   can be prepared by reaction of a compound of the formula IV    <IMAGE>  (IV)   with a base to give a compound of the formula Va or Vb    <IMAGE>  (Va)   <IMAGE>  (Vb)  and subsequent reaction with carbon nucleophiles; alternatively the compound of the formula VI is prepared by direct reaction of the compound of the formula IV e.g. with R2Cu(CN)Li2, the above substituents having the meanings mentioned.
Patent DK-0701699-T3 (DK)
Inventor: MOEN ALEXANDER ADRIANUS
IPC: G01N33/561
Filed: 1994-06-03
Granted: 1997-10-27
Abstract: The present invention relates to a method of detecting in a test subject the presence of at least one hapten, one macromolecule, one pathogen or one part thereof that causes an immune response, as well as a method of detecting any immune response to the hapten, the macromolecule, the pathogen or at least one part thereof that causes an immune response. The invention also relates to the use of said method for screening test subjects for contamination with at least one pathogen or antigen, for screening for any infection with at least one pathogen and/or for screening for an allergy to at least one hapten or antigen.
Patent DK-0677484-T3 (DK)
Inventor: SCHNORR KARL-ERNST
IPC: C05F17/02
Filed: 1995-04-13
Granted: 2001-04-23
Abstract: Water, esp. condensate, from a compost plant, is oxygenated, especially by aeration. It is then filtered by reverse osmosis. The raw condensate is first modified, to facilitate biological clarification. The content of the water, determining oxygen demand, is measured; the quantity of material to be separated out is determined. Raw condensate is inoculated, to set the metabolic functions of the micro-organisms. The predetermined material to be separated, is filtered out. Metabolism in the bio-reactor is oxygen-controlled, esp. by air input, and/or the nutrient input, and/or pH control, and/or temperature control. Filter performance, esp. membrane filter performance, is controlled by pressure and/or throughput. Also claimed are: The use of a bio-reactor, a composting process, and composting equipment. <IMAGE>
Patent DK-0721778-T3 (DK)
Inventor: LOWE JOHN A III
IPC: A61K31/137
Filed: 1995-12-07
Granted: 2004-07-12
Abstract: The present invention relates to a method of treating or preventing a disorder selected from stroke, epilepsy, head trauma, spinal cord trauma, ischemic neuronal damage such as cerebral ischemic damage from stroke or vascular occlusion (e.g., during open heart surgery), excitotoxic neuronal damage (e.g., in stroke or epilepsy) and amyotrophic lateral sclerosis in mammals, including humans, using an NK-1 antagonist. It also relates to a method of treating or preventing such disorders in mammals, including humans, using certain quinuclidine derivatives, piperidine derivatives, pyrrolidine derivatives, azanorbornane derivatives, ethylene diamine derivatives and related compounds that are substance P receptor antagonists.
Patent DK-0810892-T3 (DK)
Inventor: PIONTEK CARL J
IPC: A61J15/00
Filed: 1996-01-31
Granted: 2003-08-25
Abstract: The present invention is an improved stylet for a enteric or nasoenteric feeding tubes. In broadest terms, the present invention comprises: a stylet for a feeding tube, the stylet having: (a) a stylet hub having a bore therethrough and adapted to be attached to one end of the feeding tube, the bore having an inner surface; (b) a longitudinally extending reinforcement member adapted to extend through the feeding tube, the reinforcement member having a proximal end; and (c) a hollow member having an outer surface and having an aperture, the hollow member disposed in the bore so as to hold the inlet end of the reinforcement member between the outer surface and the inner surface through an interference fit.